biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Prothena and Management's Reporting

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Oct 01, 2022 1:10pm

189 Views

Post# 34999470

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Prothena and Management's Reporting

Lol. Puleeeeeeeze??

Every single shareholder I talk to has expressed what I have posted here in the last 2 days. You can make excuses for Bioasis but these are real questions.

But I have more that you won't so easily dismiss.

jd

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1